查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496025

全球皮下注射針市場：2024-2029 年預測

Global Hypodermic Needle Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 126 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計在預測期內，皮下注射針市場將以 6.42% 的年複合成長率成長，市場規模將從 2022 年的 3,034,881,000 美元達到 2029 年的 4,690,217,000 美元。

皮下注射針是一種醫療器械，用於通常透過皮下、肌肉或靜脈注射將物質注射到體內或從體內提取液體。皮下注射針由一根帶有鋒利尖端的中空圓形空管和柱塞組成，可以精確組織藥物、疫苗接種以及血液和其他液體的抽取。

全球皮下注射針廣告涉及醫療保健行業使用的皮下注射針的製造、分銷和銷售。市場的主要觀點包括安全針頭、非安全針頭、應用程式、最終用戶、地理接近性、管理環境、未使用的改進、行業主要參與者和開放的福利活動。安全針頭著重醫護人員安全等方面，降低針刺傷害的風險。

非安全針是沒有額外安全部件的傳統針。全球皮下注射針市場充滿活力，並受到創新進步、醫療保健方法以及需要在恢復性醫療干預中使用皮下注射針的疾病流行等因素的影響。

市場促進因素：

  • 糖尿病盛行率的增加預計將推動皮下注射針市場的成長。

由於全球糖尿病盛行率不斷上升，預計該市場將在未來幾年獲得成長動力。根據國際糖尿病聯盟提供的資訊，到2021年，大約有5.37億20歲至79歲年齡層的成年人將患有糖尿病多年。此外，預計到 2030 年，糖尿病患者人數將增至 6.43 億，到 2045 年將增至 7.83 億。

全球糖尿病支出的增加預計將大幅增加先進藥物輸送解決方案的採用。許多公司和企業正在為糖尿病患者提供先進和新穎的解決方案，例如將針插入患者體內來輕鬆輸送藥物。

  • 由於各種公司的存在，競爭分析的增加可能會加強皮下注射針市場。

近年來，一些公司和企業對市場產生了重大影響。隨著公司傾向提高其競爭優勢和全球整體市場佔有率，預計未來幾年研發支出將大幅增加。 Iskcon Surgicals 是該市場的主要企業之一，向其客戶供應和銷售一次性皮下注射針。

該公司表示，其針頭採用高精度拋光、矽化和超音波清洗技術製造。該公司的產品已通過ISO認證。其他公司也為其客戶提供先進的皮下注射針。

例如，NIPRO 是最大的針製造商之一，每年生產約 110 億支針。該公司聲明其產品並非以 PVC 或乳膠形式製造。該公司還提供各種長度和尺寸的皮下注射針。這些新興市場的開拓和趨勢預計將在預測期內在市場中發揮重要作用。

  • 氣喘和慢性病發病率的增加預計將推動皮下注射針市場的發展。

由於全球氣喘盛行率不斷上升，皮下注射針的使用預計將在預測期內急劇增加。根據世界衛生組織（WHO）資訊顯示，氣喘進一步被納入世界衛生組織《預防和控制非傳染性疾病（NCD）全球行動計畫》和聯合國2030年永續發展計畫。

世衛組織也採取多項措施改善低收入和中等收入國家的藥品運輸。隨著工業化的擴大，人們對高污染的擔憂，這是導致氣喘患者盛行率增加的主要因素之一。因此，我們預計在預測期內皮下注射針和其他藥物輸送產品的採用將會增加。

由於全球慢性感染疾病的流行，該行業預計將激增。預計這種成長將推動針頭和注射器的採用，它們似乎能夠可靠地將藥物輸送到身體系統。此外，疫苗接種率的提高預計也將推動全球對新注射劑的需求。

  • 各種有利的政府法規預計將促進皮下注射針市場的成長。

多種糖尿病和氣喘患者使用皮下注射針。這些患者需要對藥物和液體脫敏，以防特定的不良反應。世界各國政府都制定了指令和法律，允許患者攜帶皮下注射針而不受重大限制。例如，2021 年 3 月，美國馬裡蘭州參議院報告通過了一項新法案，將分發和擁有皮下注射針合法化。

此外，2021 年 10 月，紐約州政府報告稱通過了一項法案，該法案將使該州皮下注射針的分銷和銷售合法化。根據這項新法案，皮下注射針將不再被視為醫療器材。政府表示，引入新立法是為了讓人們更容易使用藥物傳輸系統。

公司產品

  • B Braun(TM)皮下注射針- B Braun(TM)皮下注射針具有光滑的表面、輕薄的矽膠塗層、自研磨拋光工藝、低摩擦潤滑、透明的針座設計、符合ISO 6009 的顏色編碼針座、廣泛的直徑和長度是為了患者的舒適度而設計的。
  • SafeTouch皮下注射針- Nipro 的 SafeTouch 皮下注射皮下注射針是一款易於使用的高品質產品，透過透明的安全裝置將針頭鎖定在其蓋內，從而降低患者和醫療保健專業人員被針刺傷的風險。
  • Monoject(TM) 皮下注射安全針 - Cardinal Health Inc. 的 Monoject(TM) 皮下注射安全針是一種易於使用的單手設備，只需拇指即可固定，提高了臨床醫生的舒適度和信心。採用雙鎖定鉸鏈臂技術，確保使用過程中和廢棄後的安全。它還具有可逆的聲音和觸覺咔嗒聲，以確保安全啟動。無菌、一次性使用且獨立包裝，對臨床醫生來說是方便且安全的選擇。

主要進展

  • 2023 年 5 月 - 確保光滑表面和精確斜角的高性能磨料對於皮下注射針的生產至關重要。 Norton Abrasives 提供切割、研磨和拋光工具，可提供卓越的效果並提高流程效率和患者舒適度。
  • 2023 年 1 月 - MTD 集團的 DropSafeTM SicuraTM 被動安全針頭獲得 FDA 批准，用於肌肉內和皮下注射疫苗和藥物。該針頭旨在消除針刺傷害並提供完全安全的注射體驗。針頭受到透明防護罩的保護，注射後會自動鎖定，無需醫療保健專業人員逐步啟動。該設備滿足了美國未滿足的提高安全性的需求，正在等待 CE 認證。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球皮下注射針市場：按類型

  • 介紹
  • 安全針
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 非安全針
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章全球皮下注射針市場：依應用分類

  • 介紹
  • 疫苗接種
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 藥物輸送
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 體液樣本採集
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章全球皮下注射針市場：依最終用戶分類

  • 介紹
  • 醫院和診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 門診治療中心
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章全球皮下注射針市場：按地區

  • 介紹
  • 北美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • B. Braun Melsungen AG
  • NIPRO
  • Cardinal Health Inc.
  • Terumo Medical Corporation
  • Smith's Group Plc
  • BD
  • Iscon Surgicals Ltd.
  • Narang Medical Ltd.
  • Medline Industries Inc.
  • Dynarex Corporation
簡介目錄
Product Code: KSI061611904

The global hypodermic needle market is expected to grow at a compound annual growth rate of 6.42% over the forecast period to reach a market size of US$4,690.217 million in 2029, from US$3,034.881 million in 2022.

A hypodermic needle is a medical instrument utilized for infusing substances or extricating liquids from the body, ordinarily through subcutaneous, intramuscular, or intravenous courses. It comprises a hollow, round, and empty tube with a sharp tip and plunger, permitting for exact organization of drugs, immunizations, or withdrawal of blood or other liquids.

The worldwide hypodermic needle advertise includes the manufacturing, distribution, and selling of hypodermic needles utilized within the healthcare industry. Key viewpoints of the market include safety needles, non-safety needles, applications, end-users, geographical nearness, administrative environment, unused improvements, industry key players, and open well-being activities. Safety needles focus on aspects like healthcare employee safety, lessening the hazard of needlestick wounds.

Non-safety needles are conventional needles without extra security components. The worldwide hypodermic needle market is energetic and affected by components such as innovative headways, healthcare approaches, and the predominance of maladies that require the utilize of hypodermic needles in restorative medical intercessions.

Market Drivers:

  • The increasing prevalence of diabetes is anticipated to boost the hypodermic needle market growth.

The market is predicted to experience a boost in the years ahead due to the increase in the prevalence rate of diabetes around the world. According to the information provided by the International Diabetes Federation, around 537 million adult individuals have been living with diabetes for years, between the ages of 20 and 79 category in the year 2021. Further, it has also been estimated that the global population living with diabetes is expected to grow to 643 million by 2030 and around 783 million by 2045.

Increasing global expenditure on diabetes has been expected to surge the adoption of advanced drug delivery solutions. Various companies and corporations have been offering advanced and novel solutions for diabetic patients, such as the easy delivery of drugs by needles in a patient's body.

  • An increase in competitive analysis due to various corporation presence would bolster the hypodermic needle market.

Several firms and corporations have been making a considerable impact in the market in the past few years. The increasing expenditure on research and development was expected to surge in the next few years as corporations tend to increase their competitive advantage and overall market share globally. Iscon Surgicals Ltd., one of the key players in the market, has been providing and selling disposable hypodermic needles to its customers.

The company stated that its needle had been produced through high and advanced precision grinding, siliconization, and ultrasonic cleaning. The company's products are ISO Certified. Other corporations have been offering advanced hypodermic needles for their customers.

For instance, NIPRO, one of the largest needle manufacturers, produces around 11 billion units annually. The company stated that its products are not manufactured as PVC or latex. It also offers hypodermic needles in different lengths and sizes. These developments and trends are expected to play a significant role in the market during the forecast period.

  • The rising rate of asthma and chronic disease is expected to propel the hypodermic needle market.

Hypodermic needle utilization is anticipated to surge within the projected period due to the expanding rate of asthma, around the world. According to the information given by the World Wellbeing Organisation (WHO), asthma is additionally included in the WHO Worldwide Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) and the United Nations 2030 Plan for Sustainable Development.

The WHO has also been undertaking a few measures to upgrade the drug conveyance segment in lower and middle-income nations. With expanding industrialization, there has been a concern around high contamination, which has been one of the major components of the expanding prevalence rate of asthmatic patients. Subsequently, it is anticipated to improve the adoption of hypodermic needles and other drug-delivery products within the projected time period.

The industry is anticipated to surge due to the rise in the predominance rate of chronic infections around the world. This increment is anticipated to boost the adoption of needles and syringes that seem to securely deliver drugs into the body system. Moreover, increasing vaccination rates were also expected to enhance the demand for novel injectable solutions, worldwide.

  • Various favorable government regulations would increase the hypodermic needle market growth.

Various patients living with diabetes and asthma condition have been utilizing hypodermic needles on their own. These patients needed to desensitize drugs and infusions in case of distinctive unfavorably susceptible reactions. Governments around the world have been facilitating the directions and laws that permit patients to carry hypodermic needles without any major confinements. For example, in March 2021, the Maryland Senate in the United States reported the passing of a novel bill decriminalizing the dispersion and ownership of hypodermic needles.

In addition, in October 2021, the New York Government reported the passing of a bill decriminalizing the distribution and sales of hypodermic needles within the state. Beneath this novel bill, hypodermic needles would not be considered as medicate gear. The government stated that the novel bill had been introduced to enhance the accessibility of the drug delivery systems to the people.

Company Product:

  • B Braun(TM) Hypodermic Needles- B Braun(TM) Hypodermic Needles are designed for patient comfort with a smooth surface, light silicone coating, automated grinding and polishing process, low-friction lubrication, transparent hub design, color-coded hubs conforming to ISO 6009, and wide range of diameters and lengths.
  • Safetouch Hypodermic Needles- Nipro's Safetouch hypodermic needles are a user-friendly, high-quality product with a transparent safety device that locks the needle inside the cover, reducing the risk of needlestick injuries for both patients and healthcare professionals.
  • Monoject(TM) Hypodermic Safety Needles- The Monoject(TM) Hypodermic Safety Needle from Cardinal Health Inc. is a user-friendly, one-handed device that provides protection with just a thumb, enhancing clinician comfort and confidence. It features double-lock hinged arm technology, ensuring safety during use and after disposal. The device also features a reversible Audible and tactile click for safety activation. It is sterile, single-use, and individually packaged, making it a convenient and safe option for clinicians.

Key Developments:

  • May 2023- High-performance abrasives are crucial for the manufacturing of hypodermic needles, ensuring smooth surfaces and precise beveling angles. Norton Abrasives offers tools for cutting, grinding, and polishing, delivering exceptional results and improving process efficiency and patient comfort.
  • January 2023- MTD Group received FDA clearance for its DropSafeTM SicuraTM passive safety needle for intramuscular and subcutaneous injection of vaccines and drugs. The needle is designed to eliminate needlestick injuries and provide a fully safe injection experience. The needle is protected by a transparent shield that automatically locks after injection, requiring no incremental activation step by healthcare professionals. The device fulfills an unmet need for increased safety in the US and is CE certification pending.

Segmentation:

Global Hypodermic Needle Market is segmented and analyzed as below:

By Type

  • Safety Hypodermic Needle
  • Non-Safety Hypodermic Needle

By Application

  • Vaccination
  • Drug delivery
  • Body Fluid Sample Collection

By End Users

  • Hospitals and Clinics
  • Ambulatory Care Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Thailand
  • Taiwan
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL HYPODERMIC NEEDLE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Safety Hypodermic Needle
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Non-Safety Hypodermic Needle
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. GLOBAL HYPODERMIC NEEDLE MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Vaccination
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Drug delivery
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Body Fluid Sample Collection
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. GLOBAL HYPODERMIC NEEDLE MARKET BY END USERS

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Ambulatory Care Centers
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL HYPODERMIC NEEDLE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. UK
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Italy
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. South Africa
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Thailand
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Taiwan
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. B. Braun Melsungen AG
  • 10.2. NIPRO
  • 10.3. Cardinal Health Inc.
  • 10.4. Terumo Medical Corporation
  • 10.5. Smith's Group Plc
  • 10.6. BD
  • 10.7. Iscon Surgicals Ltd.
  • 10.8. Narang Medical Ltd.
  • 10.9. Medline Industries Inc.
  • 10.10. Dynarex Corporation